When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 Pogledi
• 07/10/23
0
0
Ugraditi
administrator
Pretplatnici
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari